Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Study of Additional Use of Scopolamine Butylbromide, Glucagon or NPO-11 Following Single Dose of NPO-11 in Healthy Adult Men During Endoscopy

NCT00740324 is registered in ClinicalTrials.gov with Nihon Pharmaceutical Co., Ltd as lead sponsor.

NCT NCT00740324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00740324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Study of Additional Use of Scopolamine Butylbromide, Glucagon or NPO-11 Following Single Dose of NPO-11 in Healthy Adult Men During Endoscopy
Lead sponsor
Nihon Pharmaceutical Co., Ltd
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2008
Completion date
July 31, 2009
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy